Biotech Scale-Up: Prolific Machines Nets $50M Series B2 for Optogenetics-Driven Biologics

Prolific Machines raises $50M in Series B2 led by Atoms & Bits and Nant Capital, pushing total funding past $100M to accelerate its biologics platform.